828
Views
62
CrossRef citations to date
0
Altmetric
Reviews

Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies

, &

References

  • Martí-Vilalta JL, Arboix A, Mohr JP. Microangiopathies (lacunes). In: Mohr JP, Wolf PhA, Grotta JC, Moskowitz MA, Mayberg MR, von Kummer R, editors. Stroke. Pathophysiology, diagnosis, and management. 5th edition. Elsevier Saunders, Philadelphia, PA, USA; 2011; p. 485-515
  • Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke 2012;7:36-46
  • Arboix A, Martí-Vilalta JL. Lacunar stroke. Expert Rev Neurother 2009;9:179-96
  • Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neurol 1979;36:65-73
  • Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 1969;12:1-15
  • Arboix A, Martí-Vilalta JL. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease. Cerebrovasc Dis 2004;17(Suppl 1):58-62
  • Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010;9:689-701
  • Modir R, Gardener H, Wright CB. Blood pressure and white matter hyperintensity volume. A review of the relationship and implications for stroke prediction and prevention. Eur Neurol Rev 2012;8:33-6
  • Lei Ch, Lin S, Tao W, et al. Association between cerebral microbleeds and cognitive function: a systematic review. J Neurol Neurosurg Psychiatry 2013;84:693-7
  • Arauz A. Cerebral microbleeds and cognitive function. J Neurol Neurosurg Psychiatry 2012. [Epub ahead of print]
  • Martí-Vilalta JL, Arboix A. The Barcelona Stroke Registry. Eur Neurol 1999;41:135-42
  • Wardlaw J, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822-38
  • Fisher CM. Lacunar infarcts. A review. Cerebrovasc Dis 1991;1:311-20
  • Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982;32:871-6
  • Arboix A, Padilla I, García-Eroles, Massons, Comes E, Targa C. Pure motor hemiparesis: a clinical study of 222 patients. J Neurol Neurosurg Psychiatry 2001;71:239-42
  • Arboix A, García-Plata C, García-Eroles L, et al. Clinical study of 99 patients with pure sensory stroke. J Neurol 2005;252:156-62
  • Arboix A, Oliveres M, García-Eroles L, et al. Risk factors and clinical features of sensorimotor stroke. Cerebrovasc Dis 2003;16:448-51
  • Arboix A. Clinical study of 23 patients with ataxic hemiparesis. Med Clin (Barc) 2004;122:342-4
  • Arboix A, Bell Y, García-Eroles L, et al. Clinical study of 35 patients with dysarthria-clumsy hand syndrome. J Neurol Neurosurg Psychiatry 2004;75:231-4
  • Arboix A, López-Grau M, Casasnovas C, et al. Clinical study of 39 patients with atypical lacunar syndrome. J Neurol Neurosurg Psychiatry 2006;77:381-4
  • Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005;128:2507-17
  • Boiten J, Lodder J. Risk factors for lacunar infarction. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, editors. Subcortical stroke. 2 edition, Oxford University Press, NY, USA; 2002; p. 87-97
  • Arboix A, García-Eroles L, Massons J, et al. Haemorrhagic lacunar stroke. Cerebrovasc Dis 2000;10:229-34
  • Arboix A, García-Eroles L, Massons J, et al. Haemorrhagic pure motor stroke. Eur J Neurol 2007;14:219-23
  • Arboix A, Saßmannshausen A, García-Eroles L, et al. Hemorrhagic sensorimotor stroke: spectrum of disease. J Neurol Res 2011;1:90-5
  • Arboix A, Massons J, García-Eroles L, et al. Clinical predictors of lacunar syndrome not due to lacunar infarcts. BMC Neurol 2010;10:31
  • Arboix A, Martí-Vilalta JL. Lacunar syndromes not due to lacunar infarcts. Cerebrovasc Dis 1992;2.287-92
  • Mohr JP, Kase CS, Wolf PA, et al. Lacunes in the NINCDS Pilot Stroke Data Bank. [Abstract]. Ann Neurol 1982;12:84
  • van Zagten M, Boiten J, Kessels F, Lodder J. Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch Neurol 1996;53:650-5
  • Tang WK, Liang HJ, Chen YK, et al. White matter hyperintensities and quality of life in acute lacunar stroke. Neurol Sci 2012; In press
  • Loos CM, van Oostenbrugge J, Staals J. The appearance of a new white matter lesion adjacent to the old infarct in first-ever lacunar stroke patients: a two-year follow-up study with MRI. Cerebrovasc Dis 2012;34:443-5
  • van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences. Rotterdam Scan Study. Stroke 2008;39:2712-19
  • O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98
  • Kinoshita T, Okudera T, Tamura H, et al. Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke 2000;31:1646-50
  • Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130:1988-2003
  • Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004;127:2265-75
  • Han J, Gao P, Lin Y, et al. Three-tesla magnetic resonance imaging study of cerebral microbleeds in patients with ischemic stroke. Neurol Res 2009;31(9):900-3
  • Fiehler J. Cerebral microbleeds: old leaks and new haemorrhages. Int J Stroke 2006;1:122-30
  • Kato H, Izumiyama M, Izumiyama K, et al. Silent cerebral microbleeds on T2*-weighted MRI. Correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002;33:1536-40
  • Wardlaw JM, Lewis SC, Keir SL, et al. Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions? Stroke 2006;37:2633-6
  • Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989;39:1246-50
  • Arboix A, Rexach M, Subirà M, Pujadas R. Complex aortic atheroma plaques: study of 71 patients with lacunar infarcts. Med Clin (Barc) 2012;138:160-4
  • Laloux P, Broucher JM. Lacunar infarctions due to cholesterol emboli. Stroke 1991;22:1440-4
  • Waterston JA, Brown MM, Butler P, Swash M. Small deep cerebral infarcts associated with occlusive internal carotid artery disease. A hemodynamic phenomenon? Arch Neurol 1990;47:953-7
  • Arboix A, Cabeza N, Garcia-Eroles L, et al. Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke. Cerebrovasc Dis 2004;18:304-11
  • Benhaiem-Sigaux N, Gherardi R, Salama J, et al. Thrombosis of a saccular microaneurysm causing cerebral (pontine) lacunae. Acta Neuropathol (Berl) 1986;69:332-6
  • Pearce JMS, Chandrasekera CP, Ladusans EJ. Lacunar infarcts in polycythemia with raised packer cell volumes. BMJ 1983;287:935-6
  • Arboix A, Besses C, Acin P, et al. Ischemic stroke as first manifestation of essential thrombocythemia. Stroke 1995;26:1563-466
  • Kase CS, Levitz SM, Wolinsky JS, Sulis CA. Pontine pure motor hemiparesis due to meningovascular syphilis in human immunodeficiency virus-positive patients [letter]. Arch Neurol 1988;45:832
  • Barinagarrementeria F, Del Brutto OH. Lacunar syndrome due to neurocysticercosis. Arch Neurol 1989;46:415-17
  • Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009;65:194-202
  • Del Bene A, Makin SD, Doubal FN, et al. Variation in risk factors for recent small subcortical infarcts with infarct size, shape, and location. Stroke 2013;44:3000-6
  • Taheri S, Gasparovic CH, Huisa BN, et al. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 2011;42:2158-63
  • Giwa MO, Williams J, Elderfield K, et al. Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology 2012;78:167-74
  • Marie P. Des foyers lacunaires de desintegration et de differents autres etats cavitaires du cerveau. Rev Med (Paris) 1901;21:281-98
  • Ferrand J. Les lacunes de désintégration cérébrale. Paris, Thesis; 1902
  • Hughes M, Dodgson MCH. Chronic cerebral hypertensive disease. Lancet 1954;267(6842):770-4
  • Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology 1965;15:774-84
  • Fang HCH. Lacunar infarction: clinico-pathologic correlation study (Abstract). J Neuropathol Exp Neurol 1972;31:212
  • De Reuck J, Vander Eecken H. The arterial angioarchitecture in lacunar state. Acta Neurol Belg 1976;76:142-9
  • Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986;36:340-5
  • Mancardi GL, Romagnoli P, Tassinari T, et al. Lacunes and cribiform cavities of the brain. Correlations with pseudobulbar palsy and parkinsonism. Eur Neurol 1988;28:11-17
  • Tuszynski MH, Petito CK, Levy DE. Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke 1989;20:990-9
  • Dozono K, Ishii N, Nishihara Y. Horie A. an autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke 1991;22:993-6
  • Arboix A, Ferrer I, Martí-Vilalta JL. Análisis clinico-anatomopatológico de 25 pacientes con infartos lacunares. Rev Clin Esp 1996;196:370-4
  • Lammie GA. Pathology of lacunar infarction. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J, editors. Subcortical stroke. 2 edition. Oxford University Press, NY, USA;2002; p. 37-46
  • Arboix A, Martí-Vilalta JL. A study of lacunar infarcts based on analysis of the main anatomopathological series in the literature. Rev Neurol 1998;26:365-7
  • Derouesné C, Gray F, Escourelle R. Castaigne. “Expanding cerebral lacunae” in a hipertensive patient with normal pressure hydrocephalus. Neuropathol Appl Neurobiol 1987;13:309-20
  • Benhaiem-Sigaux N, Gray F, Gherardi R, et al. Expanding cerebellar lacunes due to dilatation of the perivascular space associated with Binswanger's subcortical arteriosclerotic encephalopathy. Stroke 1987;18:1087-92
  • Lammie GA, Brannan F, Wardlaw JM. Incomplete lacunar infarction (type 1b lacunes). Acta Neuropathol (Berl) 1998;96:163-71
  • Poirier J. Giant cerebral lacuna due to dilatation of the perivascular space: a case report. Clin Neuropathol 1983;2:138-40
  • Poirier J, Derouesné C. Cerebral lacunae. A proposed new classification. Clin Neuropathol 1984;3:226
  • Poirier J, Gray F, Gherardi R, Derouesné C. Cerebral lacunae. A new neuropathological classification. J Neuropathol Exp Neurol 1985;44:312
  • Arboix A, Massons J, Garcia-Eroles L, et al. Nineteen-year trends in risk factors, clinical characteristics and prognosis in lacunar infarcts. Neuroepidemiology 2010;35:231-6
  • Sacco S, Marini C, Totaro B, et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology 2006;66:1335-8
  • Norrving B. Lacunar infarcts: no black holes in the brain are benign. Pract Neurol 2008;8:222-8
  • Sacco S, Marini C, Totaro B, et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology 2006;66:1335-8
  • Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-36
  • Grau-Olivares M, Bartrés-Faz D, Arboix A, et al. Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment. Cerebrovasc Dis 2007;23:353-61
  • Arboix A. Lacunar infarct and cognitive decline. Expert Rev Neurother 2011;11:1251-4
  • Grau-Olivares M, Arboix A, Bartrés-Faz D, Junqué C. Neuropsychological abnormalities associated with lacunar infarction. J Neurol Sci 2007;257:160-5
  • Jacova C, Pearce LA, Costello R, et al. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012;72:351-62
  • Edwards JD, Jacova C, Sephehry AA, et al. A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke. Neurology 2013;80:1-8
  • Makin SD, Turpin S, Dennis MS, Wardlaw JM. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 2013;84:893-900
  • Salgado AV, Ferro JM, Gouveia-Oliveira A. Long-term prognosis of first-ever lacunar infarction. A hospital-based study. Stroke 1996;27:661-6
  • Staals J, van Raak L, Hilton A, Lodder J. Differences in long-term survival in two lacunar stroke subtypes: a 15-year follow-up study in 782 cerebral infarct patients. Cerebrovasc Dis 2008;25:26-31
  • Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2003;2:238-45
  • Del Bene A, Palumbo V, Lamassa M, et al. Progressive lacunar stroke: review of mechanisms, prognostic features, and putative treatments. Int J Stroke 2012;7:321-9
  • Chung JW, Kim BJ, Sohn CH, et al. Branch atheromatous plaque: a major cause of lacunar infarction (high-resolution MRI study). Cerebrovasc Dis 2012;2:36-44
  • Wardlaw JM, Doubal FN, Eadie E, et al. Little association between intracranial arterial stenosis and lacunar stroke. Cerebrovasc Dis 2011;31:12-18
  • Serena J, Leira R, Castillo J, et al. Neurological deterioration in acute lacunar infarctions. The role of excitatory and inhibitory neurotransmitters. Stroke 2001;32:1154-61
  • Yamamoto Y, Ohara T, Hamanaka M, et al. Predictive factors for progressive motor deficits in penetrating artery infarctions in two different arterial territories. J Neurol Sci 2010;293:87-91
  • Castellanos M, Castillo J, García MM, et al. Inflammation-mediated damage in progressing in lacunar infarction. A potential therapeutic target. Stroke 2002;33:982-7
  • Rouhl RP, Damoiseaux JG, Lodder J, et al. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging 2012;33:1800-6
  • Elkind MSV, Luna JM, Coffey CS, et al. The levels of inflammatory markers in the treatment of stroke(LIMIS) Study: inflammatory biomarkers as risk predictors after lacunar stroke. Int J Stroke 2010;5:117-25
  • Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Inflammation in ischemic stroke subtypes. Curr Pharm Des 2012;18:4289-310
  • Licata G, Tuttolomondo A, Di Raimondo D, et al. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 2009;101:929-37
  • Licata G, Tuttolomondo A, Corrao S. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetes state. Int J Immunopathol Pharmacol 2006;19:639-46
  • Ramos-Estebanez C, Moral-Arce I, Gonzalez-Manly A, et al. Vascular cognitive impairment in small vessel disease: clinical and neuropsychological features of lacunar state and Binswanger's disease. Age Ageing 2011;40:175-80
  • Appelros P, Samuelsson M, Lindell D. Lacunar infarcts: functional and cognitive outcomes at five years in relation to MRI findings. Cerebrovasc Dis 2005;20:34-40
  • Arauz A, Murillo L, Cantú C, et al. Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging. Risk factors, recurrence, and outcome in 175 consecutive cases. Stroke 2003;34:2453-8
  • Jokinen H, Gouw AA, Madureira S, et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011;76:1872-8
  • Narasimhalu K, Wiryasaputra K, Sitoh YY, Kandiah N. Post-stroke subjective cognitive impairment is associated with acute lacunar infarcts in the basal ganglia. Eur J Neurol 2012;20(3):547-51
  • Grau-Olivares M, Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother 2009;9:1201-17
  • Duering M, Zieren N, Hervé D, et al. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain 2011;134:2366-75
  • Nitkunan A, Lanfranconi S, Charlton RA, et al. Brain atrophy and cerebral small vessel disease. A prospective follow-up study. Stroke 2011;42:133-8
  • Jokinen H, Lipsanen J, Schmidt R, et al. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology 2012;78:1785-92
  • Kloppenborg RP, Nederkoorn PJ, Grool AM, et al. Cerebral small-vessel disease and progression of brain atrophy: The SMART-MR study. Neurology 2012;79:2029-36
  • Grau-Olivares M, Arboix A, Junqué C, et al. Progressive gray matter atrophy in lacunar patients with mild cognitive impairment. Cerebrovasc Dis 2010;30:157-66
  • Duering M, Righart R, Csnadi E, et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 2012;79:2025-9
  • Smith E.E, Arboix A. Focal cortical thinning is caused by remote subcortical infarcts. Spooky action at a distance. Neurology 2012;79:2016-17
  • Micheli S, Agnelli MS, Palmerini F, et al. Need for extensive diagnostic work-up for patients with lacunar stroke. J Neurol 2008;255:637-42
  • Benavente OR, Hart RG, McClure LA, The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012;367:817-25
  • Arboix A, Font A, Garro C, et al. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J Neurol Neurosurg Psychiatry 2007;78:1392-4
  • Frey JL, Snider RM, Jahnke H, Stoane J. rt-PA in lacunar infarction. Neurology 1998;50:406
  • Shobha N, Fang J, Hill MD. Do lacunar strokes benefit from thrombolysis? Evidence from the registry of the Canadian Stroke Network. Int J Stroke 2013;8(Suppl A100):45-9
  • Cocho D, Belvis R, Martí-Fàbregas JM, et al. Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol 2006;55:70-3
  • IST-3 collaborative group. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol 2013;12:768-76
  • Junghans U, Seitz RJ, Aulich A, et al. Bleeding risk of Tirofiban, a non-peptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study. Cerebrovasc Dis 2001;12:308-12
  • Philipps J, Yhomalla G, Schwarze M, Röther J. Treatment of progressive stroke with tirofibran-experience in 35 patients. Cerebrovasc Dis 2009;28:435-8
  • Martin-Schild S, Shaltoni H, Abraham AT, et al. Safety of eptifibatide for subcortical stroke progression. Cerebrovasc Dis 2009;28:595-60
  • Bang Y, Zhang S, Wu B, Liu M. Hyperglycaremia in acute lacunar stroke: A Chinese hospital-based study. Diab Vasc Dis Res. 2013;10(3):216-21
  • Catalan Society of Neurology. Official Guidelines for diagnosis and treatment. In: Cerebrovascular diseases. 2nd edition. Barcelona: Societat Catalana de Neurologia. p. 159-240
  • Benavente O, White CL, Roldan AM. Small vessel strokes. Curr Cardiol Rep 2005;7:23-8
  • Bousser MG, Eschwege E, Haguenau M, et al. AICLA controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983;14:5-14
  • Gent M, Blakeley JA, Easton D. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215-20
  • Chinese Acute Stroke Study. CAST: randomized placebo-controlled trial of early aspirin use in 20.000 patients with acute ischemic stroke. Lancet 1997;349:1641-9
  • Gotoh F, Tohgi H, Hirai S, et al. Cilostazol Stroke Prevention Study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000;9:147-57
  • Heo SH, Lee JS, Kim BJ, et al. Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients. J Neurol 2013;260:122-30
  • Yamamoto Y, Ohara T, Ishii R, et al. A combined treatment for acute larger lacunar-type infarction. J Stroke Cerebrovasc Dis 2011;20:387-94
  • Mohr JP, Thompson JLP, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-51
  • Gorelick PB, Richardson D, Kelly M, et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-57
  • Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-7
  • Amarenco P, Benavente O, Goldstein LB, et al. for the SPARCL investigators. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke 2009;40:1405-9
  • The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischemic stroke and transient ischemic attack 2008. Cerebrovasc Dis 2008;25:457-507
  • Lodder J, Bamford JM, Sandercock PAG, et al. Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke 1990;21:375-81
  • Ntaios G, Papavasileiou V, Diener H-C, et al. Non-vitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack. A systematic review and meta-analysis of randomized controlled trials. Stroke 2012;43:3298-304
  • Arboix A, Martí-Vilalta JL. Presumed cardioembolic lacunar infarcts [Letter]. Stroke 1992;23:1841-2
  • Arboix A, García-Eroles K, Massons J, et al. Lacunar infarcts in patients aged 85 years and older. Acta Neurol Scand 2000;101:25-9
  • Montaner J. Ictus Lacunar. Marge, editor. Barcelona, Spain; 2012
  • Gorter JW; for the Stroke Prevention in Reversible Ischemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Neurology 1999;53:1319-27
  • Del Río-Espínola A, Mendioroz M, Domingues-Montanari S, et al. CADASIL management or what to do when there is little one can do. Expert Rev Neurother 2009;9:197-210
  • Gomis M, Sobrino T, Ois A, et al. Plasma beta-amyloid 1-40 is associated with the diffuse of small vessel disease subtypes. Stroke 2009;40:3197-201
  • Tejada J, Díez-Tejedor E, Hernández-Echebarría L, Balboa O. Does a relationship exist between carotid stenosis and lacunar infarction? Stroke 2003;34:1404-9
  • Inzitari D, Eliasziw M, Sharpe BL, Fox AJ; Barnett HJM for the North American Symptomatic Carotid Endarterectomy Trial Group. Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. Neurology 2005;54:660-86
  • Furie KL, Goldstein LB, Albers GW, et al. on behalf of the American Heart Association Stroke; Council; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology and Council on Peripheral Vascular Disease. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012;43:3442-53
  • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665
  • Sörös P, Whitehead S, Spence JD, Hachinski V. Antihipertensive treatment can prevent stroke and cognitive decline. Nat Rev Neurol 2013;9:174-1768
  • The SPS3 Study Group. Blood pressure target in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013;382(9891):507-15
  • Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005;112:1644-50
  • Verhaaren BF, Vernooij MW, de Boer R, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013;61:1354-9
  • Takase B, Nagata M, Hattori H, et al. Combined therapeutic effect of probucol and cilostazol on endothelial function in patients with silent cerebral lacunar infarcts and hypercholesterolemia: a preliminary study. Med Princ Pract 2013;9:59-65
  • Grool AM, van der Graaf Y, Mali WP. Witkamp TD, Vincken KL, Geerlings MI; SMART Study Group. Mood problems increase the risk of mortality in patients with lacunar infarcts: the SMART-MR study. Psychosom Med 2012;74:234-40
  • Parra O, Sánchez-Armengol A, Bonnin M, et al. Early treatment of obstructive apnea and stroke outcome: a randomized controlled trial. Eur Respir J 2011;37:1128-36
  • Bonnin-Vilaplana M, Arboix A, Parra O, et al. Sleep-related breathing disorders in acute lacunar stroke. J Neurol 2009;256:2036-42
  • Di Nicolantionio JJ, Serebruany VL. Comparing ticagrelor versus clopidogrel in patients with history of cerebrovascular disease. A net clinical harm? Stroke 2012;43:3409-10
  • Topçuoglu MA, Arsava EM, Ay H. Antiplatelet resistance in stroke. Expert Rev Neurother 2011;11:251-63
  • Yamamoto Y, Craggs L, Baumann M, et al. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol 2011;37:94-113
  • Bersano A, Debette S, Zanier ER, et al. The genetics of small-vessel disease. Curr Med Chem 2012;19:4124-41
  • Dávalos A, Alvarez-Sabín J, Castillo J, et al. International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 2012;380:349-57
  • Ransom BR, Stys PK, Waxman SG. The pathophysiology of anoxic injury in central nervous system white matter. Stroke 1990;21(1 Suppl):III52-7
  • Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomized controlled trial. Lancet 2004;363:439-45
  • Aslanyan S, Weir CJ, Muir KW, Lees KR. Magnesium for treatment of acute lacunar stroke syndromes: further analysis of the IMAGES trial. Stroke 2007;38:1269-73
  • Garcia JH, Ho KL. Pathology of hypertensive arteriopathy. Neurosurg Clin N Am 1992;3(3):497-507

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.